Swartz Robin bought VYGR
November 1, 2026 · Form 4 insider transaction
Swartz Robin bought 318,500 shares of Voyager Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
318,500
Price
$0.00
Total value
N/A
InsiderSwartz Robin
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateNovember 1, 2026
Filing dateNovember 3, 2026
Shares owned after318,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This stock option was issued pursuant to the Plan. The vesting commencement date of the option is October 20, 2026. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service.